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Background
Cognitive aids help the stressed practitioner in an emer-
gency setting carry out complex tasks. Ideally, they
ensure the completion of key steps and prevent unne-
cessary ones. Malignant hyperthermia is an emergency
event that lends itself to the use of a cognitive aid.
Experts associated with the Malignant Hyperthermia
Association (MHAUS) first developed a cognitive aid in
the form of a “poster” in the mid-1980s.
Methods and results
MH experts based the “poster” on review of the current
literature, personal experience, and experience gained
from the MH Hotline. The first four versions (1991,
1993, 1995, and 1998) were formatted as a list of steps.
In the first ten years, changes were mainly to content
rather than design. For example, dantrolene administra-
tion was prioritized - Step 1 “GET HELP.GET DAN-
TROLENE,” changing the anesthesia circuit tubing and
CO2 absorbent were no longer recommended, and spe-
cific dosages were given for insulin and glucose for the
treatment of hyperkalemia.
Released in 2003, the fifth version of the MH poster
had a completely different format with three separate
sections for diagnosis (including masseter spasm and
sudden cardiac arrest in a child), acute treatment, and
post acute care. The sentences were converted to bullet
points and formatted in columns to make reading easier.
Bolded text was also used to highlight common errors,
such as failing to use sterile water to dilute the dantro-
lene, and the avoidance of calcium channel blockers. The
next two versions (2005 and 2008) retained this format
with added information on myoglobinuria and the main-
tenance of adequate urine output.
The latest version (2011), has a dramatically different
look. The most notable changes are the use of color,
pictures, and an algorithm style rather than bullet-point
steps.
Over 20,000 posters have been distributed over past sev-
eral decades. The use of the posters/algorithm has been
incorporated into simulation-based scenarios involving
MH; the posters have has been translated into different
languages, and modified for inclusion in the Stanford
Emergency Manual.
Conclusions
The MHAUS MH treatment poster was one of the, if not
the first cognitive aid to be used in anesthesia practice. It
has evolved from a simple list of steps to a visually appeal-
ing and easy to follow algorithm that incorporates all key
treatment elements and common diagnostic questions.
Although it is impossible to measure how the “poster” has
influenced the recognition and treatment of MH, the fact
that it is widely distributed and continues to be in demand
attests to its probable effectiveness.
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